Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.
about
Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulatorsEvaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents.Repurposing celecoxib as a topical antimicrobial agent.Carbon nanotubes as anti-bacterial agents.High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes.Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.Polishing the tarnished silver bullet: the quest for new antibiotics.Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serumDNA-crosslinker cisplatin eradicates bacterial persister cells.Preventing friendly fire in the war on microbes.Better living through chemistry: Addressing emerging antibiotic resistance.Drug repurposing: An approach to tackle drug resistance in S. typhimurium.In Vitro Antibacterial Activity of Phlorotannins from Edible Brown Algae, Eisenia bicyclis Against Streptomycin-Resistant Listeria monocytogenes.Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.In vitro microbicidal, anti-biofilm and cytotoxic effects of different commercial antiseptics.Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.Antibacterial Efficacy of Polysaccharide Capped Silver Nanoparticles Is Not Compromised by AcrAB-TolC Efflux Pump.Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.Virtual Screening and Biomolecular Interactions of CviR-Based Quorum Sensing Inhibitors AgainstAntimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against
P2860
Q30832528-5344E8B1-7D16-4DB4-B233-D9E5BDB3F7EDQ35736631-936FBDAF-6073-454C-A9B7-9EC86BB7AE0CQ35838503-FCF6C7D3-1293-4392-A2CA-9E70E1918F69Q35895183-A539B9C0-4138-4D6E-96DF-38F386F5DB9BQ36378952-2A89AD17-7BC1-4BBD-9606-516812D29EDCQ36410455-5F91A97F-792A-4774-B151-2F349C1AE269Q38968733-40D0DEC4-48EF-4CB4-B545-C3A81AD23159Q38980013-426B4DF8-9AA3-480A-84EB-3C9277EC1B62Q39160499-028C656D-0494-4171-BB0A-DD3EFAEE75B8Q40762973-36DE2435-4E1F-46B9-A681-3DC15D2A2782Q40777976-DB2A1AB3-70CD-4F81-A97B-D9C864981DEAQ40933611-E62DF948-5AFF-4475-A347-7DDB09F53DFBQ48096762-73D3E21D-5BEB-4A92-8A12-65CA34574384Q48146177-3B044EB0-6786-46AE-91EA-D4EBB2AD0313Q50054973-747D337D-4E10-4B2D-84FC-75609A2CC847Q50145801-F6E964B3-294E-4025-BBB4-3B7A8ACD85A7Q52672412-2A3D0696-9F5E-4137-84BD-E58CDFDE11B8Q52684515-C1D30E59-F393-4BBD-911E-A375EF7C9338Q54205018-0F1D5D3D-2FB7-4B41-B5FB-3F187F1003A2Q55484555-DCCBDD11-2802-48CF-8A9F-4ED025F61E0DQ57161193-CAB0B5DF-E459-423A-8CB3-58E4FBDE0259Q58556379-F0592A8B-BEE9-4B73-A38C-664D478CC705
P2860
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@ast
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@en
type
label
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@ast
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@en
prefLabel
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@ast
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@en
P2093
P2860
P356
P1476
Drug repurposing as an alterna ...... lcitrant bacterial infections.
@en
P2093
Adrián Rangel-Vega
Edna Ayerim Mandujano-Tinoco
Rodolfo García-Contreras
Silvia Julieta García-Contreras
P2860
P356
10.3389/FMICB.2015.00282
P577
2015-04-09T00:00:00Z